Total Voting Rights

Summary by AI BETAClose X

AstraZeneca PLC has announced that as of May 31, 2026, its issued share capital with voting rights consists of 1,551,009,750 ordinary shares, with no shares held in treasury, resulting in a total of 1,551,009,750 voting rights. This figure serves as the denominator for shareholders to determine their notification obligations under the UK Financial Conduct Authority's Disclosure and Transparency Rules.

Disclaimer*

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings